Health Catalyst EBITDA Margin 2018-2025 | HCAT
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Health Catalyst (HCAT) over the last 10 years. The current EBITDA margin for Health Catalyst as of June 30, 2025 is .
| Health Catalyst EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-06-30 | $0.32B | $-0.01B | -3.16% |
| 2025-03-31 | $0.31B | $-0.02B | -6.43% |
| 2024-12-31 | $0.31B | $-0.03B | -8.14% |
| 2024-09-30 | $0.30B | $-0.04B | -13.58% |
| 2024-06-30 | $0.30B | $-0.05B | -17.67% |
| 2024-03-31 | $0.30B | $-0.07B | -24.24% |
| 2023-12-31 | $0.30B | $-0.08B | -28.38% |
| 2023-09-30 | $0.29B | $-0.09B | -30.00% |
| 2023-06-30 | $0.28B | $-0.11B | -37.32% |
| 2023-03-31 | $0.28B | $-0.10B | -36.17% |
| 2022-12-31 | $0.28B | $-0.09B | -32.61% |
| 2022-09-30 | $0.27B | $-0.10B | -35.29% |
| 2022-06-30 | $0.27B | $-0.09B | -34.59% |
| 2022-03-31 | $0.26B | $-0.09B | -36.47% |
| 2021-12-31 | $0.24B | $-0.10B | -39.09% |
| 2021-09-30 | $0.23B | $-0.09B | -39.83% |
| 2021-06-30 | $0.22B | $-0.08B | -36.57% |
| 2021-03-31 | $0.20B | $-0.07B | -34.17% |
| 2020-12-31 | $0.19B | $-0.07B | -36.70% |
| 2020-09-30 | $0.18B | $-0.05B | -29.05% |
| 2020-06-30 | $0.17B | $-0.05B | -31.58% |
| 2020-03-31 | $0.17B | $-0.05B | -30.91% |
| 2019-12-31 | $0.16B | $-0.05B | -29.03% |
| 2019-06-30 | $0.11B | $-0.03B | -30.48% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.166B | $0.307B |
| Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Health Catalyst Inc. is based in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.812B | 58.34 |
| Tempus AI (TEM) | United States | $11.803B | 0.00 |
| Doximity (DOCS) | United States | $9.361B | 38.54 |
| Hims & Hers Health (HIMS) | United States | $8.207B | 66.76 |
| IRhythm Technologies (IRTC) | United States | $5.429B | 0.00 |
| Hinge Health (HNGE) | United States | $3.287B | 0.00 |
| Privia Health (PRVA) | United States | $2.921B | 182.69 |
| Heartflow (HTFL) | United States | $2.635B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.522B | 41.72 |
| 10x Genomics (TXG) | United States | $2.035B | 0.00 |
| Enovis (ENOV) | United States | $1.765B | 9.27 |
| Omnicell (OMCL) | United States | $1.596B | 32.62 |
| Azenta (AZTA) | United States | $1.370B | 59.76 |
| Phreesia (PHR) | United States | $1.350B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.276B | 0.00 |
| Schrodinger (SDGR) | United States | $1.267B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.915B | 0.00 |
| Claritev (CTEV) | United States | $0.730B | 0.00 |
| Talkspace (TALK) | United States | $0.535B | 107.67 |
| Veradigm (MDRX) | United States | $0.534B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.523B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Standard BioTools (LAB) | United States | $0.461B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.365B | 0.00 |
| Carlsmed (CARL) | United States | $0.338B | 0.00 |
| TruBridge (TBRG) | United States | $0.306B | 14.08 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.296B | 0.00 |
| CapsoVision (CV) | United States | $0.265B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.225B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.202B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.188B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.181B | 0.00 |
| CareCloud (CCLD) | United States | $0.135B | 7.40 |
| EUDA Health Holdings (EUDA) | Singapore | $0.113B | 0.00 |
| Outset Medical (OM) | United States | $0.089B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.076B | 0.00 |
| Pulmonx (LUNG) | United States | $0.066B | 0.00 |
| American Well (AMWL) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.036B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.032B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.024B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |